Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esther H Zhou

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 31, 2012
Characterization of long-acting beta₂-adrenergic agonists utilization in asthma patientsSigal Kaplan, Esther H Zhou, Solomon Iyasu
Pharmaceutical Medicine|July 8, 2023
The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory ActivitiesGita A Toyserkani, Joann H Lee, Esther H Zhou
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 20, 2014
Long-acting beta2-adrenergic agonist in pediatric and adolescent asthma patients, 2003-2011Esther H Zhou, Elizabeth M Kang, Sally Seymour, et al.
Medical Care|October 11, 2012
Atomoxetine use during a period of FDA actionsDongyi Tony Du, Esther H Zhou, John Goldsmith, et al.
Pharmacoepidemiology and Drug Safety|February 28, 2024
Prescriber perceptions of boxed warnings: A qualitative studyRachel N Ingersoll, Elise T Bui, Blair Coleman, et al.
The Canadian Journal of Urology|August 13, 2009
Charlson comorbidity index and success of extracorporeal shock wave lithotripsyKatherine C Hubert, Mandeep Singh, Esther H Zhou, et al.
Pharmacoepidemiology and Drug Safety|February 5, 2011
Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United StatesAngelika D Manthripragada, Esther H Zhou, Daniel S Budnitz, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 9, 2023
Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemicSara Karami, Cooma Asonye, Ellen Pinnow, et al.
Pharmacoepidemiology and Drug Safety|June 3, 2020
Changes in emergency department visits for zolpidem-attributed adverse drug reactions after FDA Drug Safety CommunicationsAndrew I Geller, Esther H Zhou, Daniel S Budnitz, et al.
Pharmacoepidemiology and Drug Safety|November 29, 2013
Risk of acute myocardial infarction, stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers - a cohort study using the Clinical Practice Research DatalinkEsther H Zhou, Kate Gelperin, Mark S Levenson, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 31, 2012
Characterization of long-acting beta₂-adrenergic agonists utilization in asthma patientsSigal Kaplan, Esther H Zhou, Solomon Iyasu
Pharmaceutical Medicine|July 8, 2023
The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory ActivitiesGita A Toyserkani, Joann H Lee, Esther H Zhou
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 20, 2014
Long-acting beta2-adrenergic agonist in pediatric and adolescent asthma patients, 2003-2011Esther H Zhou, Elizabeth M Kang, Sally Seymour, et al.
Medical Care|October 11, 2012
Atomoxetine use during a period of FDA actionsDongyi Tony Du, Esther H Zhou, John Goldsmith, et al.
Pharmacoepidemiology and Drug Safety|February 28, 2024
Prescriber perceptions of boxed warnings: A qualitative studyRachel N Ingersoll, Elise T Bui, Blair Coleman, et al.
The Canadian Journal of Urology|August 13, 2009
Charlson comorbidity index and success of extracorporeal shock wave lithotripsyKatherine C Hubert, Mandeep Singh, Esther H Zhou, et al.
Pharmacoepidemiology and Drug Safety|February 5, 2011
Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United StatesAngelika D Manthripragada, Esther H Zhou, Daniel S Budnitz, et al.
Clinical Toxicology (Philadelphia, Pa.)|March 9, 2023
Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemicSara Karami, Cooma Asonye, Ellen Pinnow, et al.
Pharmacoepidemiology and Drug Safety|June 3, 2020
Changes in emergency department visits for zolpidem-attributed adverse drug reactions after FDA Drug Safety CommunicationsAndrew I Geller, Esther H Zhou, Daniel S Budnitz, et al.
Pharmacoepidemiology and Drug Safety|November 29, 2013
Risk of acute myocardial infarction, stroke, or death in patients initiating olmesartan or other angiotensin receptor blockers - a cohort study using the Clinical Practice Research DatalinkEsther H Zhou, Kate Gelperin, Mark S Levenson, et al.
Pageof 5